|
|
|
|
| LEADER |
02979nam a22003375i 4500 |
| 001 |
978-3-319-60324-7 |
| 005 |
20191028081532.0 |
| 007 |
cr nn 008mamaa |
| 008 |
170802s2017 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783319603247
|
| 024 |
7 |
|
|a 10.1007/978-3-319-60324-7
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Mechanisms of Vascular Defects in Diabetes Mellitus
|c edited by C.C. Kartha, Surya Ramachandran, Radhakrishna M. Pillai.
|
| 250 |
|
|
|a 1st ed. 2017.
|
| 260 |
# |
# |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2017.
|
| 300 |
|
|
|a XVIII, 579 p. 75 illus., 54 illus. in color.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Advances in Biochemistry in Health and Disease ;
|v 17
|
| 505 |
0 |
|
|a Section 1 Introduction -- The Global Burden Of Diabetes And Its Vascular Complications -- SECTION 2 Pathogenesis -- Genetic Basis For Increased Risk For Vascular Diseases In Diabetes -- Vascular Remodelling In Diabetes Mellitus -- Pathogenesis Of The Plaque Vulnerability In Diabetes Mellitus -- Endothelial Dysfunction In Diabetes -- Smooth Muscle Cells In Diabetes Mellitus -- Monocytes Factors In Pathogenesis Of Vascular Lesions In Diabetes -- Endothelial Progenitor Cell Dysfunction In The Pathogenesis Of Vascular Complications Of Diabetes -- Pathogenetic mechanisms in diabetic retinopathy: from molecules to cells to tissues -- Perspectives on the vascular pathogenesis of diabetic neuropathy -- SECTION 3 Molecular mechanisms -- The Renin - Angiotensin System And Diabetes -- Adipokines And Vascular Disease In Diabetes -- G-Proteins In Vascular Complications Of Diabetes -- Histone Deacetylases In Vascular Pathophysiology: Regulation By Vasoactive Peptides And Growth Factors -- Role of non-coding RNAs in vascular complications of diabetes mellitus -- SECTION 4 Hemostatic Factors -- Diabetes As A Prothrombotic State -- Mechanisms Of Hypercoagulation And Aberrant Clot Lyses In Type 2 Diabetes -- Platelet Dysfunction In Type-2 Diabetes Mellitus -- SECTION 5 Metabolic Factors -- Advanced Glycation End Products In Diabetic Complications -- Atherogenicdyslipoproteinemia In Type 2 Diabetes Mellitus -- Vascular Remodeling: Homocysteine And Diabetes -- SECTION 6 Pharmacological Therapies -- Mechanisms Of Action Of Drugs For Treating Endothelial Dysfunction In Diabetes Mellitus -- Beneficial Effects Of Inorganic Nitrate/Nitrite On Vascular Function And Blood Pressure In Diabetes -- Myeloperoxidase (MPO): Do We Need Inhibitors?.
|
| 650 |
|
0 |
|a Cell biology.
|
| 650 |
|
0 |
|a Diabetes.
|
| 650 |
1 |
4 |
|a Cell Biology.
|
| 650 |
2 |
4 |
|a Diabetes.
|
| 700 |
1 |
|
|a Kartha, C.C.
|e editor.
|
| 700 |
1 |
|
|a Ramachandran, Surya.
|e editor.
|
| 700 |
1 |
|
|a Pillai, Radhakrishna M.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-319-60324-7
|